Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2008

Open Access 01-02-2008 | Research article

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease

Authors: Yohei Kirino, Mitsuhiro Takeno, Reikou Watanabe, Shuji Murakami, Masayoshi Kobayashi, Haruko Ideguchi, Atsushi Ihata, Shigeru Ohno, Atsuhisa Ueda, Nobuhisa Mizuki, Yoshiaki Ishigatsubo

Published in: Arthritis Research & Therapy | Issue 1/2008

Login to get access

Abstract

Introduction

Toll-like receptors (TLRs) mediate signaling that triggers activation of the innate immune system, whereas heme oxygenase (HO)-1 (an inducible heme-degrading enzyme that is induced by various stresses) suppresses inflammatory responses. We investigated the interaction between TLR and HO-1 in an inflammatory disorder, namely Behçet's disease.

Methods

Thirty-three patients with Behçet's disease and 30 healthy control individuals were included in the study. Expression levels of HO-1, TLR2 and TLR4 mRNA were semiquantitatively analyzed using a real-time PCR technique, and HO-1 protein level was determined by immunoblotting in peripheral blood mononuclear cells (PBMCs) and polymorphonuclear leukocytes. In some experiments, cells were stimulated with lipopolysaccharide or heat shock protein-60; these proteins are known to be ligands for TLR2 and 4.

Results

Levels of expression of HO-1 mRNA were significantly reduced in PBMCs from patients with active Behçet's disease, whereas those of TLR4, but not TLR2, were increased in PBMCs, regardless of disease activity. Moreover, HO-1 expression in PBMCs from patients with Behçet's disease was repressed in the presence of either lipopolysaccharide or heat shock protein-60.

Conclusion

The results suggest that upregulated TLR4 is associated with HO-1 reduction in PBMCs from patients with Behçet's disease, leading to augmented inflammatory responses.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med. 1999, 341: 1284-1291. 10.1056/NEJM199910213411707.CrossRefPubMed Sakane T, Takeno M, Suzuki N, Inaba G: Behcet's disease. N Engl J Med. 1999, 341: 1284-1291. 10.1056/NEJM199910213411707.CrossRefPubMed
2.
go back to reference Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M: Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol. 1982, 100: 1455-1458.CrossRefPubMed Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M: Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol. 1982, 100: 1455-1458.CrossRefPubMed
3.
go back to reference Sezer FN: The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol. 1953, 36: 301-315.CrossRefPubMed Sezer FN: The isolation of a virus as the cause of Behcet's diseases. Am J Ophthalmol. 1953, 36: 301-315.CrossRefPubMed
4.
go back to reference Lee S, Bang D, Cho YH, Lee ES, Sohn S: Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res. 1996, 288: 179-183.CrossRefPubMed Lee S, Bang D, Cho YH, Lee ES, Sohn S: Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behcet's disease. Arch Dermatol Res. 1996, 288: 179-183.CrossRefPubMed
5.
go back to reference Anonymous: Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease: a multicenter study. The Behcet's Disease Research Committee of Japan. J Rheumatol. 1989, 16: 506-511. Anonymous: Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease: a multicenter study. The Behcet's Disease Research Committee of Japan. J Rheumatol. 1989, 16: 506-511.
6.
7.
go back to reference Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T: Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995, 38: 426-433. 10.1002/art.1780380321.CrossRefPubMed Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T: Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995, 38: 426-433. 10.1002/art.1780380321.CrossRefPubMed
8.
go back to reference Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.CrossRefPubMed Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.CrossRefPubMed
10.
go back to reference Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000, 164: 558-561.CrossRefPubMed Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000, 164: 558-561.CrossRefPubMed
11.
go back to reference Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H: Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001, 276: 31332-31339. 10.1074/jbc.M103217200.CrossRefPubMed Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H: Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem. 2001, 276: 31332-31339. 10.1074/jbc.M103217200.CrossRefPubMed
12.
go back to reference Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP: Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003, 162: 1221-1227.PubMedCentralCrossRefPubMed Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T, Michel BA, Seger RA, Gay S, Lauener RP: Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol. 2003, 162: 1221-1227.PubMedCentralCrossRefPubMed
13.
go back to reference Frasnelli M, So A: Toll-like receptor 2 and toll-like receptor 4 expression on CD64+ monocytes in rheumatoid arthritis: comment on the article by Iwahashi et al. Arthritis Rheum. 2005, 52: 2227-2228. 10.1002/art.21113.CrossRefPubMed Frasnelli M, So A: Toll-like receptor 2 and toll-like receptor 4 expression on CD64+ monocytes in rheumatoid arthritis: comment on the article by Iwahashi et al. Arthritis Rheum. 2005, 52: 2227-2228. 10.1002/art.21113.CrossRefPubMed
14.
go back to reference Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H: Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1457-1467. 10.1002/art.20219.CrossRefPubMed Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H: Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 2004, 50: 1457-1467. 10.1002/art.20219.CrossRefPubMed
15.
go back to reference Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT: Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006, 54: 3601-3611. 10.1002/art.22197.CrossRefPubMed Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT: Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006, 54: 3601-3611. 10.1002/art.22197.CrossRefPubMed
16.
go back to reference Marshak-Rothstein A: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006, 6: 823-835. 10.1038/nri1957.CrossRefPubMed Marshak-Rothstein A: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006, 6: 823-835. 10.1038/nri1957.CrossRefPubMed
17.
go back to reference Direskeneli H, Saruhan-Direskeneli G: The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol. 2003, 21: S44-S48.PubMed Direskeneli H, Saruhan-Direskeneli G: The role of heat shock proteins in Behcet's disease. Clin Exp Rheumatol. 2003, 21: S44-S48.PubMed
18.
go back to reference Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24: 449-455. 10.1016/S1471-4906(03)00181-9.CrossRefPubMed Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24: 449-455. 10.1016/S1471-4906(03)00181-9.CrossRefPubMed
19.
go back to reference Morse D, Choi AM: Heme oxygenase-1: the 'emerging molecule' has arrived. Am J Respir Cell Mol Biol. 2002, 27: 8-16.CrossRefPubMed Morse D, Choi AM: Heme oxygenase-1: the 'emerging molecule' has arrived. Am J Respir Cell Mol Biol. 2002, 27: 8-16.CrossRefPubMed
20.
go back to reference Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, Ikehara K, Matsuse T, Ishigatsubo Y: Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther. 2001, 12: 967-979. 10.1089/104303401750195926.CrossRefPubMed Inoue S, Suzuki M, Nagashima Y, Suzuki S, Hashiba T, Tsuburai T, Ikehara K, Matsuse T, Ishigatsubo Y: Transfer of heme oxygenase 1 cDNA by a replication-deficient adenovirus enhances interleukin 10 production from alveolar macrophages that attenuates lipopolysaccharide-induced acute lung injury in mice. Hum Gene Ther. 2001, 12: 967-979. 10.1089/104303401750195926.CrossRefPubMed
21.
go back to reference Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, Nagahama K, Aoki I, Ishigatsubo Y: Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol. 2004, 138: 237-244. 10.1111/j.1365-2249.2004.02594.x.PubMedCentralCrossRefPubMed Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, Nagahama K, Aoki I, Ishigatsubo Y: Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol. 2004, 138: 237-244. 10.1111/j.1365-2249.2004.02594.x.PubMedCentralCrossRefPubMed
22.
go back to reference Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997, 94: 10925-10930. 10.1073/pnas.94.20.10925.PubMedCentralCrossRefPubMed Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997, 94: 10925-10930. 10.1073/pnas.94.20.10925.PubMedCentralCrossRefPubMed
23.
go back to reference Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999, 103: 129-135. 10.1172/JCI4165.PubMedCentralCrossRefPubMed Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999, 103: 129-135. 10.1172/JCI4165.PubMedCentralCrossRefPubMed
24.
go back to reference Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A, Kanamori H, Tanaka K, Ishigatsubo Y: Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther. 2005, 7: R616-R624. 10.1186/ar1721.PubMedCentralCrossRefPubMed Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A, Kanamori H, Tanaka K, Ishigatsubo Y: Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther. 2005, 7: R616-R624. 10.1186/ar1721.PubMedCentralCrossRefPubMed
25.
go back to reference Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, Hayashi T, Ueda A, Ishigatsubo Y: Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1132-1142. 10.1002/art.21754.CrossRefPubMed Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, Hayashi T, Ueda A, Ishigatsubo Y: Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1132-1142. 10.1002/art.21754.CrossRefPubMed
26.
go back to reference Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y: Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 2007, 56: 464-475. 10.1002/art.22370.CrossRefPubMed Kirino Y, Takeno M, Murakami S, Kobayashi M, Kobayashi H, Miura K, Ideguchi H, Ohno S, Ueda A, Ishigatsubo Y: Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. Arthritis Rheum. 2007, 56: 464-475. 10.1002/art.22370.CrossRefPubMed
27.
go back to reference Anonymous: Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990, 335: 1078-1080. Anonymous: Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990, 335: 1078-1080.
28.
go back to reference Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y: Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine. 2003, 24: 210-218. 10.1016/j.cyto.2003.09.003.CrossRefPubMed Misumi M, Hagiwara E, Takeno M, Takeda Y, Inoue Y, Tsuji T, Ueda A, Nakamura S, Ohno S, Ishigatsubo Y: Cytokine production profile in patients with Behcet's disease treated with infliximab. Cytokine. 2003, 24: 210-218. 10.1016/j.cyto.2003.09.003.CrossRefPubMed
29.
go back to reference Ricchetti GA, Williams LM, Foxwell BM: Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol. 2004, 76: 719-726. 10.1189/jlb.0104046.CrossRefPubMed Ricchetti GA, Williams LM, Foxwell BM: Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide. J Leukoc Biol. 2004, 76: 719-726. 10.1189/jlb.0104046.CrossRefPubMed
30.
go back to reference Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G, Schett G: Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J. 2005, 19: 2011-2013.PubMed Zwerina J, Tzima S, Hayer S, Redlich K, Hoffmann O, Hanslik-Schnabel B, Smolen JS, Kollias G, Schett G: Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J. 2005, 19: 2011-2013.PubMed
31.
go back to reference Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1125-1132. 10.1002/art.1780340908.CrossRefPubMed Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1125-1132. 10.1002/art.1780340908.CrossRefPubMed
32.
go back to reference Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, Aker F, Akoglu T: HSP 60 expression in mucocutaneous lesions of Behcet's disease. J Am Acad Dermatol. 2001, 45: 904-909. 10.1067/mjd.2001.117728.CrossRefPubMed Ergun T, Ince U, Eksioglu-Demiralp E, Direskeneli H, Gurbuz O, Gurses L, Aker F, Akoglu T: HSP 60 expression in mucocutaneous lesions of Behcet's disease. J Am Acad Dermatol. 2001, 45: 904-909. 10.1067/mjd.2001.117728.CrossRefPubMed
33.
go back to reference Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N: Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol. 2005, 139: 371-378. 10.1111/j.1365-2249.2005.02695.x.PubMedCentralCrossRefPubMed Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N: Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol. 2005, 139: 371-378. 10.1111/j.1365-2249.2005.02695.x.PubMedCentralCrossRefPubMed
34.
go back to reference Raffeiner B, Dejaco C, Duftner C, Kullich W, Goldberger C, Vega SC, Keller M, Grubeck-Loebenstein B, Schirmer M: Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis Res Ther. 2005, 7: R1412-1420. 10.1186/ar1840.PubMedCentralCrossRefPubMed Raffeiner B, Dejaco C, Duftner C, Kullich W, Goldberger C, Vega SC, Keller M, Grubeck-Loebenstein B, Schirmer M: Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis Res Ther. 2005, 7: R1412-1420. 10.1186/ar1840.PubMedCentralCrossRefPubMed
35.
go back to reference Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW: Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 2005, 5: 1793-1800. 10.1111/j.1600-6143.2005.00932.x.CrossRefPubMed Shen XD, Ke B, Zhai Y, Gao F, Busuttil RW, Cheng G, Kupiec-Weglinski JW: Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 2005, 5: 1793-1800. 10.1111/j.1600-6143.2005.00932.x.CrossRefPubMed
36.
go back to reference Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T: Monocyte activity in Behcet's disease. Br J Rheumatol. 1996, 35: 424-429. 10.1093/rheumatology/35.5.424.CrossRefPubMed Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoglu T: Monocyte activity in Behcet's disease. Br J Rheumatol. 1996, 35: 424-429. 10.1093/rheumatology/35.5.424.CrossRefPubMed
37.
go back to reference Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S: Cytokines in Behcet's disease. J Rheumatol. 1996, 23: 321-322.PubMed Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dundar S, Kirazli S: Cytokines in Behcet's disease. J Rheumatol. 1996, 23: 321-322.PubMed
38.
go back to reference Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993, 20: 1544-1549.PubMed Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, Ocal L, Inanc M, Capo C: Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993, 20: 1544-1549.PubMed
39.
go back to reference Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G: Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J Rheumatol. 2004, 31: 1362-1368.PubMed Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S, Ueno S, Yoshizaki K, Inaba G: Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J Rheumatol. 2004, 31: 1362-1368.PubMed
Metadata
Title
Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease
Authors
Yohei Kirino
Mitsuhiro Takeno
Reikou Watanabe
Shuji Murakami
Masayoshi Kobayashi
Haruko Ideguchi
Atsushi Ihata
Shigeru Ohno
Atsuhisa Ueda
Nobuhisa Mizuki
Yoshiaki Ishigatsubo
Publication date
01-02-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2367

Other articles of this Issue 1/2008

Arthritis Research & Therapy 1/2008 Go to the issue